nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—CYP3A5—Beclomethasone—psoriasis	0.0361	0.0472	CbGbCtD
Nelfinavir—CYP1A2—Clobetasol propionate—psoriasis	0.0354	0.0463	CbGbCtD
Nelfinavir—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0326	0.0427	CbGbCtD
Nelfinavir—SLCO1A2—Prednisolone—psoriasis	0.0293	0.0383	CbGbCtD
Nelfinavir—SLCO1A2—Hydrocortisone—psoriasis	0.0278	0.0363	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—psoriasis	0.0277	0.0361	CbGbCtD
Nelfinavir—SLCO1A2—Cyclosporine—psoriasis	0.0262	0.0343	CbGbCtD
Nelfinavir—ABCG2—Mycophenolate mofetil—psoriasis	0.0259	0.0339	CbGbCtD
Nelfinavir—SLCO1B1—Cyclosporine—psoriasis	0.0247	0.0323	CbGbCtD
Nelfinavir—CYP2B6—Cholecalciferol—psoriasis	0.021	0.0275	CbGbCtD
Nelfinavir—ABCG2—Hydrocortisone—psoriasis	0.0208	0.0272	CbGbCtD
Nelfinavir—ABCG2—Cyclosporine—psoriasis	0.0196	0.0257	CbGbCtD
Nelfinavir—CYP1A2—Methoxsalen—psoriasis	0.0186	0.0243	CbGbCtD
Nelfinavir—SLCO1A2—Dexamethasone—psoriasis	0.0173	0.0226	CbGbCtD
Nelfinavir—CYP2D6—Hydroxyurea—psoriasis	0.0168	0.0219	CbGbCtD
Nelfinavir—CYP3A7—Hydrocortisone—psoriasis	0.0154	0.0201	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0154	0.0201	CbGbCtD
Nelfinavir—CYP3A7—Cyclosporine—psoriasis	0.0145	0.019	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0145	0.019	CbGbCtD
Nelfinavir—CYP3A5—Mycophenolate mofetil—psoriasis	0.0144	0.0188	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—psoriasis	0.0139	0.0181	CbGbCtD
Nelfinavir—CYP2C19—Cholecalciferol—psoriasis	0.0134	0.0175	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—psoriasis	0.0131	0.0171	CbGbCtD
Nelfinavir—ABCG2—Dexamethasone—psoriasis	0.0129	0.0169	CbGbCtD
Nelfinavir—CYP3A4—Calcitriol—psoriasis	0.0125	0.0164	CbGbCtD
Nelfinavir—CYP3A5—Hydrocortisone—psoriasis	0.0115	0.0151	CbGbCtD
Nelfinavir—CYP2C9—Cholecalciferol—psoriasis	0.0111	0.0145	CbGbCtD
Nelfinavir—CYP3A5—Cyclosporine—psoriasis	0.0109	0.0142	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—psoriasis	0.0104	0.0136	CbGbCtD
Nelfinavir—CYP2D6—Cholecalciferol—psoriasis	0.0102	0.0133	CbGbCtD
Nelfinavir—CYP3A4—Methoxsalen—psoriasis	0.00975	0.0127	CbGbCtD
Nelfinavir—CYP3A7—Dexamethasone—psoriasis	0.00956	0.0125	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00956	0.0125	CbGbCtD
Nelfinavir—ABCB1—Mycophenolate mofetil—psoriasis	0.00935	0.0122	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—psoriasis	0.00926	0.0121	CbGbCtD
Nelfinavir—CYP2B6—Dexamethasone—psoriasis	0.0091	0.0119	CbGbCtD
Nelfinavir—CYP2C19—Cyclosporine—psoriasis	0.00878	0.0115	CbGbCtD
Nelfinavir—ABCB1—Betamethasone—psoriasis	0.00802	0.0105	CbGbCtD
Nelfinavir—ABCB1—Prednisolone—psoriasis	0.00791	0.0103	CbGbCtD
Nelfinavir—ABCB1—Hydrocortisone—psoriasis	0.0075	0.00981	CbGbCtD
Nelfinavir—ABCB1—Prednisone—psoriasis	0.00747	0.00977	CbGbCtD
Nelfinavir—CYP2C9—Cyclosporine—psoriasis	0.0073	0.00954	CbGbCtD
Nelfinavir—CYP3A5—Dexamethasone—psoriasis	0.00717	0.00937	CbGbCtD
Nelfinavir—ABCB1—Cyclosporine—psoriasis	0.00708	0.00926	CbGbCtD
Nelfinavir—CYP2D6—Cyclosporine—psoriasis	0.00667	0.00873	CbGbCtD
Nelfinavir—CYP3A4—Cholecalciferol—psoriasis	0.00646	0.00844	CbGbCtD
Nelfinavir—CYP2C19—Dexamethasone—psoriasis	0.00578	0.00756	CbGbCtD
Nelfinavir—CYP3A4—Triamcinolone—psoriasis	0.0056	0.00732	CbGbCtD
Nelfinavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.0056	0.00732	CbGbCtD
Nelfinavir—CYP2C9—Dexamethasone—psoriasis	0.00481	0.00628	CbGbCtD
Nelfinavir—CYP3A4—Betamethasone—psoriasis	0.00481	0.00628	CbGbCtD
Nelfinavir—CYP3A4—Prednisolone—psoriasis	0.00474	0.0062	CbGbCtD
Nelfinavir—ABCB1—Dexamethasone—psoriasis	0.00467	0.0061	CbGbCtD
Nelfinavir—CYP3A4—Hydrocortisone—psoriasis	0.00449	0.00588	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—psoriasis	0.00448	0.00585	CbGbCtD
Nelfinavir—CYP2D6—Dexamethasone—psoriasis	0.0044	0.00575	CbGbCtD
Nelfinavir—CYP3A4—Cyclosporine—psoriasis	0.00424	0.00555	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—psoriasis	0.00375	0.0049	CbGbCtD
Nelfinavir—CYP3A4—Dexamethasone—psoriasis	0.0028	0.00365	CbGbCtD
Nelfinavir—Mitiglinide—PPARG—psoriasis	0.00191	1	CrCbGaD
Nelfinavir—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.00133	0.0508	CbGpPWpGaD
Nelfinavir—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00112	0.0426	CbGpPWpGaD
Nelfinavir—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00101	0.0384	CbGpPWpGaD
Nelfinavir—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000926	0.0353	CbGpPWpGaD
Nelfinavir—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000918	0.035	CbGpPWpGaD
Nelfinavir—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000864	0.0329	CbGpPWpGaD
Nelfinavir—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.000826	0.0315	CbGpPWpGaD
Nelfinavir—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000807	0.0308	CbGpPWpGaD
Nelfinavir—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000624	0.0238	CbGpPWpGaD
Nelfinavir—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000574	0.0219	CbGpPWpGaD
Nelfinavir—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000569	0.0217	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IL22—psoriasis	0.000489	0.0186	CbGpPWpGaD
Nelfinavir—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000486	0.0185	CbGpPWpGaD
Nelfinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000464	0.0177	CbGpPWpGaD
Nelfinavir—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000458	0.0174	CbGpPWpGaD
Nelfinavir—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000404	0.0154	CbGpPWpGaD
Nelfinavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000376	0.0143	CbGpPWpGaD
Nelfinavir—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000375	0.0143	CbGpPWpGaD
Nelfinavir—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000343	0.0131	CbGpPWpGaD
Nelfinavir—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000339	0.0129	CbGpPWpGaD
Nelfinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000335	0.0128	CbGpPWpGaD
Nelfinavir—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000331	0.0126	CbGpPWpGaD
Nelfinavir—ABCG2—Iron uptake and transport—CP—psoriasis	0.000313	0.0119	CbGpPWpGaD
Nelfinavir—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000278	0.0106	CbGpPWpGaD
Nelfinavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000272	0.0104	CbGpPWpGaD
Nelfinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000259	0.00988	CbGpPWpGaD
Nelfinavir—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000256	0.00975	CbGpPWpGaD
Nelfinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000238	0.00909	CbGpPWpGaD
Nelfinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000236	0.00901	CbGpPWpGaD
Nelfinavir—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000235	0.00897	CbGpPWpGaD
Nelfinavir—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000233	0.00889	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000222	0.00846	CbGpPWpGaD
Nelfinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00021	0.00801	CbGpPWpGaD
Nelfinavir—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000202	0.00771	CbGpPWpGaD
Nelfinavir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000202	0.0077	CbGpPWpGaD
Nelfinavir—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.0002	0.00761	CbGpPWpGaD
Nelfinavir—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000199	0.0076	CbGpPWpGaD
Nelfinavir—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000197	0.00751	CbGpPWpGaD
Nelfinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000193	0.00737	CbGpPWpGaD
Nelfinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000192	0.0073	CbGpPWpGaD
Nelfinavir—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000164	0.00624	CbGpPWpGaD
Nelfinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000158	0.00601	CbGpPWpGaD
Nelfinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000156	0.00594	CbGpPWpGaD
Nelfinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000154	0.00586	CbGpPWpGaD
Nelfinavir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00015	0.00574	CbGpPWpGaD
Nelfinavir—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000148	0.00563	CbGpPWpGaD
Nelfinavir—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000146	0.00555	CbGpPWpGaD
Nelfinavir—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000144	0.0055	CbGpPWpGaD
Nelfinavir—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000142	0.00543	CbGpPWpGaD
Nelfinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000126	0.00482	CbGpPWpGaD
Nelfinavir—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000125	0.00475	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.00012	0.00457	CbGpPWpGaD
Nelfinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000116	0.00443	CbGpPWpGaD
Nelfinavir—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000112	0.00425	CbGpPWpGaD
Nelfinavir—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00011	0.0042	CbGpPWpGaD
Nelfinavir—Ill-defined disorder—Betamethasone—psoriasis	0.00011	0.000532	CcSEcCtD
Nelfinavir—Ill-defined disorder—Dexamethasone—psoriasis	0.00011	0.000532	CcSEcCtD
Nelfinavir—Discomfort—Triamcinolone—psoriasis	0.00011	0.000531	CcSEcCtD
Nelfinavir—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00011	0.00419	CbGpPWpGaD
Nelfinavir—Hyperhidrosis—Hydrocortisone—psoriasis	0.000109	0.000529	CcSEcCtD
Nelfinavir—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000109	0.000529	CcSEcCtD
Nelfinavir—Pain—Cyclosporine—psoriasis	0.000109	0.000527	CcSEcCtD
Nelfinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000109	0.00414	CbGpPWpGaD
Nelfinavir—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000108	0.00413	CbGpPWpGaD
Nelfinavir—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000108	0.000522	CcSEcCtD
Nelfinavir—Anorexia—Hydrocortisone—psoriasis	0.000108	0.000522	CcSEcCtD
Nelfinavir—Diarrhoea—Mycophenolic acid—psoriasis	0.000108	0.000521	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—psoriasis	0.000108	0.00052	CcSEcCtD
Nelfinavir—Angiopathy—Prednisone—psoriasis	0.000108	0.00052	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000107	0.000519	CcSEcCtD
Nelfinavir—Immune system disorder—Prednisone—psoriasis	0.000107	0.000518	CcSEcCtD
Nelfinavir—Malaise—Dexamethasone—psoriasis	0.000107	0.000517	CcSEcCtD
Nelfinavir—Malaise—Betamethasone—psoriasis	0.000107	0.000517	CcSEcCtD
Nelfinavir—Oedema—Triamcinolone—psoriasis	0.000107	0.000515	CcSEcCtD
Nelfinavir—Pain—Mycophenolate mofetil—psoriasis	0.000106	0.000514	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—psoriasis	0.000106	0.000512	CcSEcCtD
Nelfinavir—Feeling abnormal—Cyclosporine—psoriasis	0.000105	0.000508	CcSEcCtD
Nelfinavir—Insomnia—Prednisolone—psoriasis	0.000105	0.000507	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—psoriasis	0.000104	0.000505	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Cyclosporine—psoriasis	0.000104	0.000504	CcSEcCtD
Nelfinavir—Dizziness—Mycophenolic acid—psoriasis	0.000104	0.000504	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—psoriasis	0.000104	0.000503	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisolone—psoriasis	0.000104	0.000503	CcSEcCtD
Nelfinavir—Malnutrition—Prednisone—psoriasis	0.000103	0.000499	CcSEcCtD
Nelfinavir—Erythema—Prednisone—psoriasis	0.000103	0.000499	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000103	0.000499	CcSEcCtD
Nelfinavir—Hyperhidrosis—Triamcinolone—psoriasis	0.000103	0.000498	CcSEcCtD
Nelfinavir—Convulsion—Betamethasone—psoriasis	0.000103	0.000497	CcSEcCtD
Nelfinavir—Convulsion—Dexamethasone—psoriasis	0.000103	0.000497	CcSEcCtD
Nelfinavir—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000103	0.00391	CbGpPWpGaD
Nelfinavir—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000102	0.000495	CcSEcCtD
Nelfinavir—Insomnia—Hydrocortisone—psoriasis	0.000102	0.000495	CcSEcCtD
Nelfinavir—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000102	0.00388	CbGpPWpGaD
Nelfinavir—Paraesthesia—Hydrocortisone—psoriasis	0.000102	0.000492	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000102	0.000491	CcSEcCtD
Nelfinavir—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000101	0.00386	CbGpPWpGaD
Nelfinavir—Urticaria—Cyclosporine—psoriasis	0.000101	0.000489	CcSEcCtD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	0.000101	0.00386	CbGpPWpGaD
Nelfinavir—Myalgia—Betamethasone—psoriasis	0.000101	0.000488	CcSEcCtD
Nelfinavir—Myalgia—Dexamethasone—psoriasis	0.000101	0.000488	CcSEcCtD
Nelfinavir—Abdominal pain—Cyclosporine—psoriasis	0.000101	0.000487	CcSEcCtD
Nelfinavir—Body temperature increased—Cyclosporine—psoriasis	0.000101	0.000487	CcSEcCtD
Nelfinavir—Anxiety—Betamethasone—psoriasis	0.000101	0.000486	CcSEcCtD
Nelfinavir—Anxiety—Dexamethasone—psoriasis	0.000101	0.000486	CcSEcCtD
Nelfinavir—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.0001	0.00383	CbGpPWpGaD
Nelfinavir—Vomiting—Mycophenolic acid—psoriasis	0.0001	0.000484	CcSEcCtD
Nelfinavir—Discomfort—Dexamethasone—psoriasis	9.97e-05	0.000482	CcSEcCtD
Nelfinavir—Discomfort—Betamethasone—psoriasis	9.97e-05	0.000482	CcSEcCtD
Nelfinavir—Dyspepsia—Hydrocortisone—psoriasis	9.97e-05	0.000482	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—psoriasis	9.96e-05	0.000482	CcSEcCtD
Nelfinavir—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	9.95e-05	0.00379	CbGpPWpGaD
Nelfinavir—Rash—Mycophenolic acid—psoriasis	9.93e-05	0.00048	CcSEcCtD
Nelfinavir—Dermatitis—Mycophenolic acid—psoriasis	9.92e-05	0.00048	CcSEcCtD
Nelfinavir—Pain—Prednisolone—psoriasis	9.92e-05	0.000479	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—psoriasis	9.91e-05	0.000479	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—psoriasis	9.91e-05	0.000479	CcSEcCtD
Nelfinavir—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	9.9e-05	0.00377	CbGpPWpGaD
Nelfinavir—Urticaria—Mycophenolate mofetil—psoriasis	9.88e-05	0.000477	CcSEcCtD
Nelfinavir—Headache—Mycophenolic acid—psoriasis	9.87e-05	0.000477	CcSEcCtD
Nelfinavir—Decreased appetite—Hydrocortisone—psoriasis	9.84e-05	0.000476	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—psoriasis	9.84e-05	0.000476	CcSEcCtD
Nelfinavir—Abdominal pain—Mycophenolate mofetil—psoriasis	9.83e-05	0.000475	CcSEcCtD
Nelfinavir—Body temperature increased—Mycophenolate mofetil—psoriasis	9.83e-05	0.000475	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.78e-05	0.000473	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Triamcinolone—psoriasis	9.72e-05	0.00047	CcSEcCtD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.69e-05	0.00369	CbGpPWpGaD
Nelfinavir—Pain—Hydrocortisone—psoriasis	9.68e-05	0.000468	CcSEcCtD
Nelfinavir—Oedema—Betamethasone—psoriasis	9.68e-05	0.000468	CcSEcCtD
Nelfinavir—Oedema—Dexamethasone—psoriasis	9.68e-05	0.000468	CcSEcCtD
Nelfinavir—Insomnia—Triamcinolone—psoriasis	9.64e-05	0.000466	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—psoriasis	9.58e-05	0.000463	CcSEcCtD
Nelfinavir—Paraesthesia—Triamcinolone—psoriasis	9.58e-05	0.000463	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisolone—psoriasis	9.56e-05	0.000462	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—psoriasis	9.54e-05	0.000461	CcSEcCtD
Nelfinavir—Dyspnoea—Triamcinolone—psoriasis	9.51e-05	0.00046	CcSEcCtD
Nelfinavir—Agitation—Prednisone—psoriasis	9.49e-05	0.000459	CcSEcCtD
Nelfinavir—Thrombocytopenia—Betamethasone—psoriasis	9.47e-05	0.000458	CcSEcCtD
Nelfinavir—Thrombocytopenia—Dexamethasone—psoriasis	9.47e-05	0.000458	CcSEcCtD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	9.43e-05	0.00359	CbGpPWpGaD
Nelfinavir—Hypersensitivity—Cyclosporine—psoriasis	9.39e-05	0.000454	CcSEcCtD
Nelfinavir—Dyspepsia—Triamcinolone—psoriasis	9.39e-05	0.000454	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—psoriasis	9.37e-05	0.000453	CcSEcCtD
Nelfinavir—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	9.36e-05	0.00357	CbGpPWpGaD
Nelfinavir—Nausea—Mycophenolic acid—psoriasis	9.36e-05	0.000452	CcSEcCtD
Nelfinavir—Hyperhidrosis—Betamethasone—psoriasis	9.35e-05	0.000452	CcSEcCtD
Nelfinavir—Hyperhidrosis—Dexamethasone—psoriasis	9.35e-05	0.000452	CcSEcCtD
Nelfinavir—Feeling abnormal—Hydrocortisone—psoriasis	9.33e-05	0.000451	CcSEcCtD
Nelfinavir—Malaise—Prednisone—psoriasis	9.31e-05	0.00045	CcSEcCtD
Nelfinavir—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	9.29e-05	0.00354	CbGpPWpGaD
Nelfinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.28e-05	0.00354	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-C—psoriasis	9.26e-05	0.00353	CbGpPWpGaD
Nelfinavir—Eye disorder—Methotrexate—psoriasis	9.26e-05	0.000448	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Hydrocortisone—psoriasis	9.26e-05	0.000448	CcSEcCtD
Nelfinavir—Anorexia—Dexamethasone—psoriasis	9.22e-05	0.000446	CcSEcCtD
Nelfinavir—Anorexia—Betamethasone—psoriasis	9.22e-05	0.000446	CcSEcCtD
Nelfinavir—Urticaria—Prednisolone—psoriasis	9.21e-05	0.000445	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—IL13—psoriasis	9.21e-05	0.00351	CbGpPWpGaD
Nelfinavir—Hypersensitivity—Mycophenolate mofetil—psoriasis	9.16e-05	0.000443	CcSEcCtD
Nelfinavir—Asthenia—Cyclosporine—psoriasis	9.14e-05	0.000442	CcSEcCtD
Nelfinavir—Pain—Triamcinolone—psoriasis	9.12e-05	0.000441	CcSEcCtD
Nelfinavir—Pruritus—Cyclosporine—psoriasis	9.02e-05	0.000436	CcSEcCtD
Nelfinavir—Urticaria—Hydrocortisone—psoriasis	9e-05	0.000435	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—psoriasis	8.99e-05	0.000435	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—psoriasis	8.95e-05	0.000433	CcSEcCtD
Nelfinavir—Abdominal pain—Hydrocortisone—psoriasis	8.95e-05	0.000433	CcSEcCtD
Nelfinavir—Body temperature increased—Hydrocortisone—psoriasis	8.95e-05	0.000433	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—psoriasis	8.95e-05	0.000432	CcSEcCtD
Nelfinavir—Asthenia—Mycophenolate mofetil—psoriasis	8.92e-05	0.000431	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Betamethasone—psoriasis	8.82e-05	0.000426	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.82e-05	0.000426	CcSEcCtD
Nelfinavir—Pruritus—Mycophenolate mofetil—psoriasis	8.79e-05	0.000425	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—psoriasis	8.79e-05	0.000425	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—psoriasis	8.79e-05	0.000425	CcSEcCtD
Nelfinavir—Feeling abnormal—Triamcinolone—psoriasis	8.79e-05	0.000425	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—psoriasis	8.76e-05	0.000423	CcSEcCtD
Nelfinavir—Insomnia—Dexamethasone—psoriasis	8.75e-05	0.000423	CcSEcCtD
Nelfinavir—Insomnia—Betamethasone—psoriasis	8.75e-05	0.000423	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	8.73e-05	0.000422	CcSEcCtD
Nelfinavir—Diarrhoea—Cyclosporine—psoriasis	8.72e-05	0.000421	CcSEcCtD
Nelfinavir—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.7e-05	0.00332	CbGpPWpGaD
Nelfinavir—Paraesthesia—Betamethasone—psoriasis	8.69e-05	0.00042	CcSEcCtD
Nelfinavir—Paraesthesia—Dexamethasone—psoriasis	8.69e-05	0.00042	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—psoriasis	8.68e-05	0.00042	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—psoriasis	8.63e-05	0.000417	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—psoriasis	8.63e-05	0.000417	CcSEcCtD
Nelfinavir—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.58e-05	0.00327	CbGpPWpGaD
Nelfinavir—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.56e-05	0.00326	CbGpPWpGaD
Nelfinavir—Hypersensitivity—Prednisolone—psoriasis	8.54e-05	0.000413	CcSEcCtD
Nelfinavir—Dyspepsia—Betamethasone—psoriasis	8.52e-05	0.000412	CcSEcCtD
Nelfinavir—Dyspepsia—Dexamethasone—psoriasis	8.52e-05	0.000412	CcSEcCtD
Nelfinavir—Diarrhoea—Mycophenolate mofetil—psoriasis	8.51e-05	0.000411	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—IL17A—psoriasis	8.47e-05	0.00323	CbGpPWpGaD
Nelfinavir—Urticaria—Triamcinolone—psoriasis	8.47e-05	0.00041	CcSEcCtD
Nelfinavir—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	8.43e-05	0.00321	CbGpPWpGaD
Nelfinavir—Body temperature increased—Triamcinolone—psoriasis	8.43e-05	0.000407	CcSEcCtD
Nelfinavir—Dizziness—Cyclosporine—psoriasis	8.43e-05	0.000407	CcSEcCtD
Nelfinavir—Oedema—Prednisone—psoriasis	8.43e-05	0.000407	CcSEcCtD
Nelfinavir—Decreased appetite—Dexamethasone—psoriasis	8.41e-05	0.000407	CcSEcCtD
Nelfinavir—Decreased appetite—Betamethasone—psoriasis	8.41e-05	0.000407	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Dexamethasone—psoriasis	8.35e-05	0.000404	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Betamethasone—psoriasis	8.35e-05	0.000404	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—psoriasis	8.35e-05	0.000403	CcSEcCtD
Nelfinavir—Hypersensitivity—Hydrocortisone—psoriasis	8.34e-05	0.000403	CcSEcCtD
Nelfinavir—Pain—Dexamethasone—psoriasis	8.27e-05	0.0004	CcSEcCtD
Nelfinavir—Pain—Betamethasone—psoriasis	8.27e-05	0.0004	CcSEcCtD
Nelfinavir—Dizziness—Mycophenolate mofetil—psoriasis	8.22e-05	0.000397	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—psoriasis	8.18e-05	0.000396	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—psoriasis	8.15e-05	0.000394	CcSEcCtD
Nelfinavir—Asthenia—Hydrocortisone—psoriasis	8.13e-05	0.000393	CcSEcCtD
Nelfinavir—Vomiting—Cyclosporine—psoriasis	8.1e-05	0.000392	CcSEcCtD
Nelfinavir—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.1e-05	0.00309	CbGpPWpGaD
Nelfinavir—Rash—Cyclosporine—psoriasis	8.03e-05	0.000388	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—psoriasis	8.03e-05	0.000388	CcSEcCtD
Nelfinavir—Dermatitis—Cyclosporine—psoriasis	8.03e-05	0.000388	CcSEcCtD
Nelfinavir—Pruritus—Hydrocortisone—psoriasis	8.01e-05	0.000387	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—psoriasis	8.01e-05	0.000387	CcSEcCtD
Nelfinavir—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	8.01e-05	0.00305	CbGpPWpGaD
Nelfinavir—Headache—Cyclosporine—psoriasis	7.98e-05	0.000386	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—psoriasis	7.97e-05	0.000386	CcSEcCtD
Nelfinavir—Feeling abnormal—Dexamethasone—psoriasis	7.97e-05	0.000385	CcSEcCtD
Nelfinavir—Feeling abnormal—Betamethasone—psoriasis	7.97e-05	0.000385	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Dexamethasone—psoriasis	7.91e-05	0.000382	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Betamethasone—psoriasis	7.91e-05	0.000382	CcSEcCtD
Nelfinavir—Vomiting—Mycophenolate mofetil—psoriasis	7.9e-05	0.000382	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—IL12B—psoriasis	7.88e-05	0.003	CbGpPWpGaD
Nelfinavir—Hypersensitivity—Triamcinolone—psoriasis	7.86e-05	0.00038	CcSEcCtD
Nelfinavir—Rash—Mycophenolate mofetil—psoriasis	7.84e-05	0.000379	CcSEcCtD
Nelfinavir—Dermatitis—Mycophenolate mofetil—psoriasis	7.83e-05	0.000379	CcSEcCtD
Nelfinavir—Headache—Mycophenolate mofetil—psoriasis	7.79e-05	0.000376	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—psoriasis	7.78e-05	0.000376	CcSEcCtD
Nelfinavir—Diarrhoea—Hydrocortisone—psoriasis	7.75e-05	0.000375	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—psoriasis	7.72e-05	0.000373	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—HLA-E—psoriasis	7.69e-05	0.00293	CbGpPWpGaD
Nelfinavir—Urticaria—Dexamethasone—psoriasis	7.69e-05	0.000372	CcSEcCtD
Nelfinavir—Urticaria—Betamethasone—psoriasis	7.69e-05	0.000372	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—psoriasis	7.68e-05	0.000371	CcSEcCtD
Nelfinavir—Dizziness—Prednisolone—psoriasis	7.67e-05	0.000371	CcSEcCtD
Nelfinavir—Asthenia—Triamcinolone—psoriasis	7.65e-05	0.00037	CcSEcCtD
Nelfinavir—Abdominal pain—Betamethasone—psoriasis	7.65e-05	0.00037	CcSEcCtD
Nelfinavir—Body temperature increased—Dexamethasone—psoriasis	7.65e-05	0.00037	CcSEcCtD
Nelfinavir—Abdominal pain—Dexamethasone—psoriasis	7.65e-05	0.00037	CcSEcCtD
Nelfinavir—Body temperature increased—Betamethasone—psoriasis	7.65e-05	0.00037	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—psoriasis	7.62e-05	0.000368	CcSEcCtD
Nelfinavir—Nausea—Cyclosporine—psoriasis	7.57e-05	0.000366	CcSEcCtD
Nelfinavir—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.57e-05	0.00289	CbGpPWpGaD
Nelfinavir—Paraesthesia—Prednisone—psoriasis	7.57e-05	0.000366	CcSEcCtD
Nelfinavir—Pruritus—Triamcinolone—psoriasis	7.54e-05	0.000365	CcSEcCtD
Nelfinavir—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.5e-05	0.00286	CbGpPWpGaD
Nelfinavir—Dizziness—Hydrocortisone—psoriasis	7.49e-05	0.000362	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—psoriasis	7.48e-05	0.000361	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—psoriasis	7.42e-05	0.000359	CcSEcCtD
Nelfinavir—Nausea—Mycophenolate mofetil—psoriasis	7.38e-05	0.000357	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—psoriasis	7.35e-05	0.000355	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—psoriasis	7.35e-05	0.000355	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—psoriasis	7.32e-05	0.000354	CcSEcCtD
Nelfinavir—Rash—Prednisolone—psoriasis	7.31e-05	0.000353	CcSEcCtD
Nelfinavir—Dermatitis—Prednisolone—psoriasis	7.3e-05	0.000353	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	7.3e-05	0.000353	CcSEcCtD
Nelfinavir—Headache—Prednisolone—psoriasis	7.26e-05	0.000351	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—psoriasis	7.26e-05	0.000351	CcSEcCtD
Nelfinavir—Vomiting—Hydrocortisone—psoriasis	7.2e-05	0.000348	CcSEcCtD
Nelfinavir—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	7.19e-05	0.00274	CbGpPWpGaD
Nelfinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.16e-05	0.00273	CbGpPWpGaD
Nelfinavir—Rash—Hydrocortisone—psoriasis	7.14e-05	0.000345	CcSEcCtD
Nelfinavir—Dermatitis—Hydrocortisone—psoriasis	7.13e-05	0.000345	CcSEcCtD
Nelfinavir—Headache—Hydrocortisone—psoriasis	7.09e-05	0.000343	CcSEcCtD
Nelfinavir—Dizziness—Triamcinolone—psoriasis	7.05e-05	0.000341	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—psoriasis	6.94e-05	0.000336	CcSEcCtD
Nelfinavir—Asthenia—Dexamethasone—psoriasis	6.94e-05	0.000336	CcSEcCtD
Nelfinavir—Asthenia—Betamethasone—psoriasis	6.94e-05	0.000336	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—psoriasis	6.89e-05	0.000333	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—psoriasis	6.89e-05	0.000333	CcSEcCtD
Nelfinavir—Nausea—Prednisolone—psoriasis	6.89e-05	0.000333	CcSEcCtD
Nelfinavir—Pruritus—Dexamethasone—psoriasis	6.85e-05	0.000331	CcSEcCtD
Nelfinavir—Pruritus—Betamethasone—psoriasis	6.85e-05	0.000331	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—psoriasis	6.84e-05	0.000331	CcSEcCtD
Nelfinavir—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	6.84e-05	0.00261	CbGpPWpGaD
Nelfinavir—Hyperhidrosis—Methotrexate—psoriasis	6.81e-05	0.000329	CcSEcCtD
Nelfinavir—Vomiting—Triamcinolone—psoriasis	6.78e-05	0.000328	CcSEcCtD
Nelfinavir—Nausea—Hydrocortisone—psoriasis	6.73e-05	0.000325	CcSEcCtD
Nelfinavir—Rash—Triamcinolone—psoriasis	6.72e-05	0.000325	CcSEcCtD
Nelfinavir—Dermatitis—Triamcinolone—psoriasis	6.72e-05	0.000325	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—psoriasis	6.71e-05	0.000324	CcSEcCtD
Nelfinavir—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.71e-05	0.00256	CbGpPWpGaD
Nelfinavir—Urticaria—Prednisone—psoriasis	6.69e-05	0.000324	CcSEcCtD
Nelfinavir—Headache—Triamcinolone—psoriasis	6.68e-05	0.000323	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—psoriasis	6.66e-05	0.000322	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—psoriasis	6.66e-05	0.000322	CcSEcCtD
Nelfinavir—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.62e-05	0.00252	CbGpPWpGaD
Nelfinavir—Diarrhoea—Betamethasone—psoriasis	6.62e-05	0.00032	CcSEcCtD
Nelfinavir—Diarrhoea—Dexamethasone—psoriasis	6.62e-05	0.00032	CcSEcCtD
Nelfinavir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.47e-05	0.00247	CbGpPWpGaD
Nelfinavir—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.44e-05	0.00245	CbGpPWpGaD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—psoriasis	6.42e-05	0.00031	CcSEcCtD
Nelfinavir—Dizziness—Dexamethasone—psoriasis	6.4e-05	0.000309	CcSEcCtD
Nelfinavir—Dizziness—Betamethasone—psoriasis	6.4e-05	0.000309	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—psoriasis	6.37e-05	0.000308	CcSEcCtD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	6.36e-05	0.00243	CbGpPWpGaD
Nelfinavir—Nausea—Triamcinolone—psoriasis	6.33e-05	0.000306	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—psoriasis	6.32e-05	0.000306	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—psoriasis	6.28e-05	0.000303	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—psoriasis	6.26e-05	0.000303	CcSEcCtD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	6.25e-05	0.00238	CbGpPWpGaD
Nelfinavir—Hypersensitivity—Prednisone—psoriasis	6.21e-05	0.0003	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—psoriasis	6.2e-05	0.0003	CcSEcCtD
Nelfinavir—Vomiting—Dexamethasone—psoriasis	6.15e-05	0.000297	CcSEcCtD
Nelfinavir—Vomiting—Betamethasone—psoriasis	6.15e-05	0.000297	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—psoriasis	6.12e-05	0.000296	CcSEcCtD
Nelfinavir—Rash—Dexamethasone—psoriasis	6.1e-05	0.000295	CcSEcCtD
Nelfinavir—Rash—Betamethasone—psoriasis	6.1e-05	0.000295	CcSEcCtD
Nelfinavir—Dermatitis—Betamethasone—psoriasis	6.09e-05	0.000295	CcSEcCtD
Nelfinavir—Dermatitis—Dexamethasone—psoriasis	6.09e-05	0.000295	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—psoriasis	6.08e-05	0.000294	CcSEcCtD
Nelfinavir—Headache—Betamethasone—psoriasis	6.06e-05	0.000293	CcSEcCtD
Nelfinavir—Headache—Dexamethasone—psoriasis	6.06e-05	0.000293	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—psoriasis	6.05e-05	0.000292	CcSEcCtD
Nelfinavir—Pain—Methotrexate—psoriasis	6.02e-05	0.000291	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—psoriasis	5.96e-05	0.000288	CcSEcCtD
Nelfinavir—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	5.92e-05	0.00226	CbGpPWpGaD
Nelfinavir—Feeling abnormal—Methotrexate—psoriasis	5.8e-05	0.000281	CcSEcCtD
Nelfinavir—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.79e-05	0.00221	CbGpPWpGaD
Nelfinavir—Diarrhoea—Prednisone—psoriasis	5.77e-05	0.000279	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—IL10—psoriasis	5.76e-05	0.0022	CbGpPWpGaD
Nelfinavir—Gastrointestinal pain—Methotrexate—psoriasis	5.76e-05	0.000278	CcSEcCtD
Nelfinavir—Nausea—Betamethasone—psoriasis	5.75e-05	0.000278	CcSEcCtD
Nelfinavir—Nausea—Dexamethasone—psoriasis	5.75e-05	0.000278	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—IL4—psoriasis	5.6e-05	0.00214	CbGpPWpGaD
Nelfinavir—Urticaria—Methotrexate—psoriasis	5.59e-05	0.00027	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—psoriasis	5.57e-05	0.000269	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—psoriasis	5.57e-05	0.000269	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—psoriasis	5.57e-05	0.000269	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—HLA-B—psoriasis	5.48e-05	0.00209	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	5.47e-05	0.00209	CbGpPWpGaD
Nelfinavir—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.46e-05	0.00208	CbGpPWpGaD
Nelfinavir—Vomiting—Prednisone—psoriasis	5.36e-05	0.000259	CcSEcCtD
Nelfinavir—Rash—Prednisone—psoriasis	5.31e-05	0.000257	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—psoriasis	5.31e-05	0.000257	CcSEcCtD
Nelfinavir—Headache—Prednisone—psoriasis	5.28e-05	0.000255	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—psoriasis	5.19e-05	0.000251	CcSEcCtD
Nelfinavir—SLCO1A2—Metabolism—NDUFA5—psoriasis	5.12e-05	0.00195	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.1e-05	0.00194	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.08e-05	0.00193	CbGpPWpGaD
Nelfinavir—Asthenia—Methotrexate—psoriasis	5.05e-05	0.000244	CcSEcCtD
Nelfinavir—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	5.02e-05	0.00191	CbGpPWpGaD
Nelfinavir—Nausea—Prednisone—psoriasis	5e-05	0.000242	CcSEcCtD
Nelfinavir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.99e-05	0.0019	CbGpPWpGaD
Nelfinavir—Pruritus—Methotrexate—psoriasis	4.98e-05	0.000241	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—psoriasis	4.82e-05	0.000233	CcSEcCtD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.77e-05	0.00182	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	4.76e-05	0.00181	CbGpPWpGaD
Nelfinavir—Dizziness—Methotrexate—psoriasis	4.66e-05	0.000225	CcSEcCtD
Nelfinavir—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.64e-05	0.00177	CbGpPWpGaD
Nelfinavir—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	4.54e-05	0.00173	CbGpPWpGaD
Nelfinavir—Vomiting—Methotrexate—psoriasis	4.48e-05	0.000216	CcSEcCtD
Nelfinavir—Rash—Methotrexate—psoriasis	4.44e-05	0.000215	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—psoriasis	4.44e-05	0.000214	CcSEcCtD
Nelfinavir—Headache—Methotrexate—psoriasis	4.41e-05	0.000213	CcSEcCtD
Nelfinavir—SLCO1B1—Metabolism—NDUFA5—psoriasis	4.38e-05	0.00167	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CYP2S1—psoriasis	4.35e-05	0.00166	CbGpPWpGaD
Nelfinavir—Nausea—Methotrexate—psoriasis	4.18e-05	0.000202	CcSEcCtD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	4.17e-05	0.00159	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.08e-05	0.00156	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.07e-05	0.00155	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NDUFA5—psoriasis	4.05e-05	0.00154	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NDUFA5—psoriasis	4.02e-05	0.00153	CbGpPWpGaD
Nelfinavir—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	3.88e-05	0.00148	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	3.77e-05	0.00144	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NDUFA5—psoriasis	3.74e-05	0.00143	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CYP2S1—psoriasis	3.72e-05	0.00142	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.6e-05	0.00137	CbGpPWpGaD
Nelfinavir—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	3.59e-05	0.00137	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	3.47e-05	0.00132	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.47e-05	0.00132	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP2S1—psoriasis	3.45e-05	0.00131	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP2S1—psoriasis	3.42e-05	0.0013	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—IFNG—psoriasis	3.39e-05	0.00129	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.38e-05	0.00129	CbGpPWpGaD
Nelfinavir—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	3.31e-05	0.00126	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP2S1—psoriasis	3.18e-05	0.00121	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.15e-05	0.0012	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	3.15e-05	0.0012	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NDUFA5—psoriasis	2.97e-05	0.00113	CbGpPWpGaD
Nelfinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.95e-05	0.00113	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NDUFA5—psoriasis	2.9e-05	0.00111	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.7e-05	0.00103	CbGpPWpGaD
Nelfinavir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.7e-05	0.00103	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.59e-05	0.000989	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.56e-05	0.000975	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP2S1—psoriasis	2.53e-05	0.000963	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2S1—psoriasis	2.47e-05	0.000941	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.28e-05	0.000869	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NDUFA5—psoriasis	2.25e-05	0.000856	CbGpPWpGaD
Nelfinavir—ABCB1—Allograft Rejection—TNF—psoriasis	2.19e-05	0.000836	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NDUFA5—psoriasis	2.19e-05	0.000835	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.18e-05	0.000831	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CARM1—psoriasis	2.13e-05	0.00081	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.09e-05	0.000798	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NDUFA5—psoriasis	2.06e-05	0.000787	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NDUFA5—psoriasis	2.05e-05	0.00078	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.04e-05	0.000776	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.99e-05	0.000757	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.95e-05	0.000744	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.94e-05	0.000741	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP2S1—psoriasis	1.91e-05	0.000728	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.91e-05	0.000728	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2S1—psoriasis	1.86e-05	0.00071	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CARM1—psoriasis	1.82e-05	0.000693	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2S1—psoriasis	1.76e-05	0.000669	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NDUFA5—psoriasis	1.75e-05	0.000667	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2S1—psoriasis	1.74e-05	0.000663	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.7e-05	0.000648	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CARM1—psoriasis	1.68e-05	0.000642	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CARM1—psoriasis	1.67e-05	0.000636	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.63e-05	0.000622	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CARM1—psoriasis	1.55e-05	0.000592	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2S1—psoriasis	1.49e-05	0.000567	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.44e-05	0.000551	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.39e-05	0.00053	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NDUFA5—psoriasis	1.35e-05	0.000515	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CAT—psoriasis	1.31e-05	0.000498	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.26e-05	0.000481	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CARM1—psoriasis	1.23e-05	0.00047	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CARM1—psoriasis	1.21e-05	0.00046	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2S1—psoriasis	1.15e-05	0.000438	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CAT—psoriasis	1.12e-05	0.000426	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.08e-05	0.000412	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CAT—psoriasis	1.04e-05	0.000395	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CAT—psoriasis	1.03e-05	0.000391	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—APOE—psoriasis	1.02e-05	0.000387	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1e-05	0.000381	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CAT—psoriasis	9.55e-06	0.000364	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	9.54e-06	0.000364	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CARM1—psoriasis	9.32e-06	0.000355	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.12e-06	0.000348	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CARM1—psoriasis	9.1e-06	0.000347	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PPARG—psoriasis	8.85e-06	0.000337	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.71e-06	0.000332	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—APOE—psoriasis	8.69e-06	0.000331	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CARM1—psoriasis	8.57e-06	0.000327	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CARM1—psoriasis	8.5e-06	0.000324	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—APOE—psoriasis	8.04e-06	0.000307	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—APOE—psoriasis	7.97e-06	0.000304	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.95e-06	0.000303	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.79e-06	0.000297	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CAT—psoriasis	7.59e-06	0.000289	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PPARG—psoriasis	7.57e-06	0.000288	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—APOE—psoriasis	7.42e-06	0.000283	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CAT—psoriasis	7.42e-06	0.000283	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CARM1—psoriasis	7.26e-06	0.000277	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PPARG—psoriasis	7.01e-06	0.000267	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PPARG—psoriasis	6.94e-06	0.000265	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.79e-06	0.000259	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PPARG—psoriasis	6.46e-06	0.000246	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOE—psoriasis	5.9e-06	0.000225	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOE—psoriasis	5.76e-06	0.00022	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAT—psoriasis	5.73e-06	0.000219	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CARM1—psoriasis	5.61e-06	0.000214	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAT—psoriasis	5.6e-06	0.000213	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAT—psoriasis	5.27e-06	0.000201	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAT—psoriasis	5.23e-06	0.000199	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PPARG—psoriasis	5.14e-06	0.000196	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PPARG—psoriasis	5.02e-06	0.000191	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAT—psoriasis	4.47e-06	0.00017	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOE—psoriasis	4.46e-06	0.00017	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOE—psoriasis	4.35e-06	0.000166	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOE—psoriasis	4.1e-06	0.000156	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOE—psoriasis	4.06e-06	0.000155	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PPARG—psoriasis	3.88e-06	0.000148	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PPARG—psoriasis	3.79e-06	0.000144	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PPARG—psoriasis	3.57e-06	0.000136	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PPARG—psoriasis	3.54e-06	0.000135	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOE—psoriasis	3.47e-06	0.000132	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAT—psoriasis	3.45e-06	0.000131	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPARG—psoriasis	3.02e-06	0.000115	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOE—psoriasis	2.68e-06	0.000102	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPARG—psoriasis	2.33e-06	8.9e-05	CbGpPWpGaD
